1,5-benzodiazepine derivatives as cck-a receptor agonists

Details 1,5-benzodiazepine derivatives as cck-a receptor agonists 1,5-benzodiazepine derivatives as cck-a receptor agonists

C - Chemistry, Metallurgy

07

D

C07D 243/12 (2006.01) A61K 31/551 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2370801

An enantiomerically enriched compound of Formula (I) is disclosed, processes for its preparation, pharmaceutical compositions containing it and the use therefore, for the treatment of CCK-A mediated diseases or conditions, such as obesity.

La présente invention concerne un composé énantiomériquement enrichi représenté par la formule (I), des processus permettant de le préparer, des compositions pharmaceutiques le contenant et l'utilisation de celles-ci, dans le cadre du traitement des maladies induites par CCK-A ou d'états, tels que l'obésité.

Affiliated with

Also associated with

Rating

1,5-benzodiazepine derivatives as cck-a receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,5-benzodiazepine derivatives as cck-a receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,5-benzodiazepine derivatives as cck-a receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1826712